Circulating Neuropeptide Y as a Biomarker for Neuromodulation in Atrial Fibrillation

JACC Clin Electrophysiol. 2020 Nov;6(12):1575-1576. doi: 10.1016/j.jacep.2020.08.025.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrial Fibrillation* / therapy
  • Biomarkers
  • Humans
  • Neuropeptide Y*

Substances

  • Biomarkers
  • Neuropeptide Y